Cell-type Specific Epigenomic and Transcriptomic Alterations in the Frontal Cortex of Individuals with Schizophrenia and the Impact of Antipsychotic Treatment
Schizophrenia subjects exhibit thousands of neuronal and non-neuronal epigenetic differences at regions associated with schizophrenia risk, and antipsychotic treatment reverses some of these alterations while inducing additional epigenomic changes.